Although IL-6 has a protective effect, its excessive amounts during COVID-19 infection attract other cytokines and chemokines, leading to CRS which, in turn, causes increased vascular permeability, ARDS, and increased susceptibility to IPA [11]. This evidence concerns the gene IL6 and Ito hypomelanosis.